Veracyte Inc (VCYT) Company Profile & Statistics

Veracyte Inc
VCYT
(Nasdaq - US)
Closed
19.86
+0.41 (+2.11%)
in:usd•As of: Apr 22, 2024 15:59 UTC -4
Open
19.46
High
20.16
Low
19.22

About Veracyte Inc

CEO

Marc Stapley

Headquarters

6000 shoreline court, suite 300

south san francisco, ca 94080, united states

Auditor

Ernst & Young LLP

Employees

815

Share Holders

Website

www.veracyte.com

Industry

medical specialties

Sector

health technology

Company Overview

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Veracyte Inc Statistics

Valuation Measures

Market Capitalization ²	1.49B
Enterprise Value	1.27B
Enterprise Value/EBITDA (ttm)	-21.75
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.36
Price to Sales (ttm)	4.04
Price to Cash (ytd)	209.56

Profitability

Gross Margin (ttm)	68.69%
Operating Margin (ttm)	-5.96%
Profit Margin (ttm)	-20.20%
Return on Equity (ttm)	-2.02%
Return on Invested Capital (ttm)	-7.04%
Return on Assets (ttm)	-1.89%

Income Statement

Revenue (ttm)	361.05M
Revenue Per Share (ttm)	4.81
Gross Profit (ttm)	248.15M
EBITDA (ttm)³	-58.61M
Net Income Avi to Common (ttm)	-74.40M
Diluted EPS (ttm)	-1.03

Share Statistics

Beta (5Y Monthly)	1.62
52-Week Change	-14.43%
S&P500 52-Week Change	21.12%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	75.07M
Dividend Yield	0.00%
Float ⁴	73.12M
% Held by Insiders	2.60%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	216.45M
Total Cash Per Share (mrq)	2.88
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.66%
Quick Ratio (mrq)	4.40%
Book Value Per Share (mrq)	14.25

Cash Flow

Operating Cash Flow Per Share (ytd)	0.61
Free Cash Flow (ytd)	34.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Veracyte Inc

Trade With A Regulated Broker